IgG Isotype Quantification via Integrated Capture Reagents
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Commercial manufacturing processes for protein biologics, such as protein IgG molecules, are lengthy, expensive, and require high production levels from genetically engineered cell lines, necessitating efficient methods for determining IgG antibody isotype concentrations to optimize production.
Innovation Solution
Methods involving the use of microtiter plates to incubate biological samples with detectably labeled target IgG proteins and isotype-specific capture reagents to form binding complexes, allowing for the determination of IgG antibody isotype concentrations through signal detection, with optional serial dilutions for standard curve generation and cell viability assessment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional IgG concentration determination methods are used, then sample processing is required including dilution and wash steps, but this increases assay complexity and potential sources of error
Solution Approach 1:
The patent combines the capture reagent and detection reagent into a single integrated reagent that performs both functions. This eliminates the need for separate capture and detection steps, thereby removing dilution and wash steps while maintaining measurement accuracy for IgG concentration determination
Solution Approach 2:
The invention creates a universal reagent that can simultaneously function as both capture and detection reagent. This multi-functional reagent binds to IgG antibodies and provides detectable signal, simplifying the overall assay procedure while preserving quantitative accuracy
2Reliability
If multiple wash steps are performed to ensure complete removal of unbound reagents, then measurement reliability improves, but assay time and operational complexity increase
Solution Approach 1:
By merging capture and detection functions into one reagent, the patent eliminates the need for wash steps that would otherwise be required to remove unbound capture reagents before adding detection reagents. This reduces assay time while maintaining signal detection reliability through the integrated design
3Measurement precision
If sample dilution is performed to optimize detection sensitivity, then measurement precision improves, but sample integrity may be compromised and additional processing steps are required
Solution Approach 1:
The invention extracts the need for sample dilution by designing an integrated reagent with sufficient sensitivity to detect IgG antibodies at optimal concentrations directly in undiluted or minimally processed samples. The enhanced sensitivity of the combined reagent compensates for any concentration variations without requiring dilution steps
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables precise quantification of IgG antibody isotypes without sample dilution, simplifying the assay workflow and improving data integrity by eliminating wash steps, thus enhancing the efficiency and accuracy of protein biologic production processes.
Implementation Method 1
incubating biological samples containing IgG antibodies with detection reagents, wherein the detection reagents comprise one or more detectably labeled target IgG protein isotypes
Implementation Method 2
incubating the IgG antibody-target IgG protein mixture in each well with one or more IgG isotype-specific populations of capture reagents, wherein each IgG isotype-specific population of capture reagents comprises binding molecules that selectively bind to a different specific IgG protein isotype
Data Source
AI summary
Disclosed herein are methods and reagents for determining immunoglobulin gamma (IgG) antibody isotype concentration from biological samples, and for analyzing a plurality of cell samples for IgG antibody production.